Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Secondary Antibodies
  5. Goat Secondary Antibodies
  6. NB483701

Goat anti-Human IgG Fc Secondary Antibody, DyLight 680, Novus Biologicals™
SDP

Catalog No. NB483701 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB483701 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB483701 Supplier Novus Biologicals Supplier No. NBP175002FR
Only null left
Add to Cart
Add to Cart

Description

Goat Polyclonal Antibody

IgG Fc Polyclonal antibody specifically detects IgG Fc in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoassay, Immunomicroscopy, Chemiluminescence Immunoassay

Specifications

Antigen IgG Fc
Applications Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoassay, Immunomicroscopy, Chemiluminescence Immunoassay (CIA)
Classification Polyclonal
Conjugate DyLight 680
Formulation 50 mM Sodium Borate
Host Species Goat
Immunogen Purified Human IgG, Fc fragment
Purification Method Affinity purified
Quantity 1 mL
Regulatory Status RUO
Primary or Secondary Secondary
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.